Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NeuroThera® Effectiveness and Safety Trial - 2 (NEST-2) A Double Blind, Randomized, Controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Effectiveness of the Treatment of Acute Ischemic Stroke With the NeuroThera® Laser System Within 24 Hours From Stroke Onset

NCT00419705 is registered in ClinicalTrials.gov with PhotoThera, Inc as lead sponsor.

NCT NCT00419705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00419705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NeuroThera® Effectiveness and Safety Trial - 2 (NEST-2) A Double Blind, Randomized, Controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Effectiveness of the Treatment of Acute Ischemic Stroke With the NeuroThera® Laser System Within 24 Hours From Stroke Onset
Lead sponsor
PhotoThera, Inc
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
July 31, 2008
Enrollment
660 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke